Target intelligence / Profile preview

RNA, U4 small nuclear 66, pseudogene (RNU4-66P)

Target
RNU4-66P
Molecular classification
Other (non-coding RNA pseudogene)
01

Overview

RNU4-66P (RNA, U4 small nuclear 66, pseudogene) is a **pseudogene** of the U4 small nuclear RNA (snRNA) family[1]. U4 snRNA is a component of the spliceosome, a large ribonucleoprotein complex essential for pre-mRNA splicing, but pseudogenes like RNU4-66P do **not** encode functional RNA and are generally considered non-functional remnants in the genome derived from the functional U4 snRNA genes[1]. There is no evidence or published data indicating that RNU4-66P is transcribed, produces functional RNA, or is involved in any therapeutic mechanism, disease association, or drug interactions[1]. The naming convention, linking "pseudogene" directly to "66" in the abbreviation, confirms this is not a protein, enzyme, receptor, transporter, transcription factor, or any classical drug target. RNU4-66P should not be considered a therapeutic target; it is annotated as a **pseudogene**, meaning there is no evidence for any canonical biological function or clinical relevance[1]. If the intent was to find a functional member of the U4 snRNA family (such as RNU4-2, which is disease-associated and biologically active[3][4][5]), this entry is **incorrect** for the purposes of drug targeting, therapy, or molecular function discovery. **Additional notes:** - **Pseudogenes** are not regarded as drug targets unless there is very specific evidence of biological activity, which does not exist for RNU4-66P. - The presence of "pseudogene" in the name, continued lack of function annotation, and the absence of any listing in disease roles or drug association databases confirms that this is not a relevant target for therapeutic, biomarker, or drug development purposes[1]. **Summary of structured information:** - The provided entry "RNU4-66P" is a pseudogene, not a functional molecule or receptor. - The entry is **incorrect** if the intent was a therapeutically actionable target, chromatin modifier, signaling molecule, or transcript relevant in disease. If information about a functional U4 small nuclear RNA molecule is needed, consider reviewing "RNA, U4 small nuclear 2 (RNU4-2)", which is implicated in spliceosome function and neurodevelopmental disorders[3][4][5].

Other names
RNU4-66PU4 snRNA pseudogene 66

Beyond the preview

Go deeper on RNA, U4 small nuclear 66, pseudogene (RNU4-66P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U4 small nuclear 66, pseudogene (RNU4-66P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call